» Articles » PMID: 35504038

Environmentally Responsible and Cost-Effective Synthesis of the Antimalarial Drug Pyronaridine

Overview
Journal Org Lett
Specialties Biochemistry
Chemistry
Date 2022 May 3
PMID 35504038
Authors
Affiliations
Soon will be listed here.
Abstract

Two routes to the antimalarial drug Pyronaridine are described. The first is a linear sequence that includes a two-step, one-pot transformation in an aqueous surfactant medium, leading to an overall yield of 87%. Alternatively, a convergent route utilizes a telescoped three-step sequence involving an initial neat reaction, followed by two steps performed under aqueous micellar catalysis conditions affording Pyronaridine in 95% overall yield. Comparisons to existing literature performed exclusively in organic solvents reveal a 5-fold decrease in environmental impact as measured by E Factors.

Citing Articles

Harnessing the 12 Green Chemistry Principles for Sustainable Antiparasitic Drugs: Toward the One Health Approach.

Martinengo B, Diamanti E, Uliassi E, Bolognesi M ACS Infect Dis. 2024; 10(6):1856-1870.

PMID: 38724015 PMC: 11184551. DOI: 10.1021/acsinfecdis.4c00172.


A sustainable, efficient, and potentially cost-effective approach to the antimalarial drug candidate MMV688533.

Kavthe R, Iyer K, Caravez J, Lipshutz B Chem Sci. 2023; 14(23):6399-6407.

PMID: 37325157 PMC: 10266478. DOI: 10.1039/d3sc01699d.


An Efficient and Sustainable Synthesis of the Antimalarial Drug Tafenoquine.

Kavthe R, Kincaid J, Lipshutz B ACS Sustain Chem Eng. 2022; 10(50):16896-16902.

PMID: 36569493 PMC: 9768812. DOI: 10.1021/acssuschemeng.2c05628.


A sustainable synthesis of the SARS-CoV-2 M inhibitor nirmatrelvir, the active ingredient in Paxlovid.

Kincaid J, Caravez J, Iyer K, Kavthe R, Fleck N, Aue D Commun Chem. 2022; 5(1):156.

PMID: 36465589 PMC: 9685088. DOI: 10.1038/s42004-022-00758-5.


Cascade Processes with Micellar Reaction Media: Recent Advances and Future Directions.

Tang C, McInnes B Molecules. 2022; 27(17).

PMID: 36080376 PMC: 9458028. DOI: 10.3390/molecules27175611.

References
1.
Kremer M . Pharmaceuticals and the developing world. J Econ Perspect. 2004; 16(4):67-90. DOI: 10.1257/089533002320950984. View

2.
Hayashi Y . Pot economy and one-pot synthesis. Chem Sci. 2017; 7(2):866-880. PMC: 5529999. DOI: 10.1039/c5sc02913a. View

3.
Rottmann M, Jonat B, Gumpp C, Dhingra S, Giddins M, Yin X . Preclinical Antimalarial Combination Study of M5717, a Plasmodium falciparum Elongation Factor 2 Inhibitor, and Pyronaridine, a Hemozoin Formation Inhibitor. Antimicrob Agents Chemother. 2020; 64(4). PMC: 7179297. DOI: 10.1128/AAC.02181-19. View

4.
Pradines B, Briolant S, Henry M, Oeuvray C, Baret E, Amalvict R . Absence of association between pyronaridine in vitro responses and polymorphisms in genes involved in quinoline resistance in Plasmodium falciparum. Malar J. 2010; 9:339. PMC: 3224917. DOI: 10.1186/1475-2875-9-339. View

5.
Krishna S, Augustin Y, Wang J, Xu C, Staines H, Platteeuw H . Repurposing Antimalarials to Tackle the COVID-19 Pandemic. Trends Parasitol. 2020; 37(1):8-11. PMC: 7572038. DOI: 10.1016/j.pt.2020.10.003. View